Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 15, 2007 (Vol. 27, No. 10)

Biology News Net

URL:www.biologynews.net
  • Comprehensive approach to news
  • None
If this issue’s columns have a theme, it is that many of the sites reviewed are focused on news. The lead item in this respect is Biology News Net, which seems to know all, see all, and tell all and is the poster child of the group. With links to an amazing array of informative news articles relating to biology, Biology News Net draws from an impressive set of sources, including Scientific American, Reuters, AP, Discovery Channel, the NIH, Nature, MSNBC, Slashdot, ScienceNow, and National Geographic. Once you max out on the news, the site offers a Forum to participate in and a weekly newsletter. Last, its collection of job listings is as impressive as any I have seen. Biology News Net provides outstanding and free services to its readers and deserves to be bookmarked widely.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »